Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

BACKGROUND: Phosphodiesterase type 5 inhibitor (PE5i) administration may stimulate the proliferation and survival of melanocytes. However, discrepancies remain regarding the association between PDE5i use and melanoma risk in observational studies in humans. AIM: To evaluate the association between P...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xinming, Han, Yan, Zheng, Yongsheng, Sun, Qiang, Ma, Tao, Dai, Li, Zhang, Junyi, Xu, Lianji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804137/
https://www.ncbi.nlm.nih.gov/pubmed/29440918
http://dx.doi.org/10.2147/OTT.S142637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804137/
https://www.ncbi.nlm.nih.gov/pubmed/29440918
http://dx.doi.org/10.2147/OTT.S142637

Ejemplares similares